Coffee consumption by type and risk of digestive cancer: a large prospective cohort study

    Research output: Contribution to journalArticle

    Published

    Standard

    Harvard

    APA

    Vancouver

    Author

    Bibtex

    @article{9df440fc264448aa8c7dce1f855b719f,
    title = "Coffee consumption by type and risk of digestive cancer: a large prospective cohort study",
    abstract = "Background:Inverse associations have been observed between coffee consumption and liver cancer, but associations for other digestive cancers are unclear. Few previous studies have investigated coffee type (specifically instant or ground coffee) or a range of digestive cancer types within one cohort. We therefore investigated coffee consumption by type and digestive cancer risks in a population-based cohort.Methods:The UK Biobank captured self-reported coffee consumption and cancer-registry recorded incident digestive cancers. Hazard ratios (HRs) and 95{\%} CIs were calculated using Cox regression. The risk of every type of digestive cancer was investigated in association with coffee consumption by dose–response and by coffee type (decaffeinated, instant and ground).Results:Over 7.5 years of follow-up, 3567 developed digestive cancer among 471,779 participants. There were 88 cases of hepatocellular carcinoma and a marked association was observed for hepatocellular carcinoma in coffee drinkers (HR 0.50, 95{\%} CI 0.29, 0.87), which was similar for instant (HR 0.51, 95{\%} CI 0.28, 0.93) and ground coffee (HR 0.47, 95{\%} CI 0.20, 1.08). We did not observe significant consistently reduced risks of other individual digestive cancers amongst coffee drinkers.Conclusions:We found some evidence that coffee consumption was inversely associated with hepatocellular carcinoma which was similar by coffee type.",
    author = "Tran, {Kim Tu} and Coleman, {Helen G.} and McMenamin, {{\'U}na C.} and Cardwell, {Chris R.}",
    year = "2019",
    month = "5",
    day = "1",
    doi = "10.1038/s41416-019-0465-y",
    language = "English",
    volume = "120",
    pages = "1059–1066",
    journal = "British Journal of Cancer",
    issn = "0007-0920",
    publisher = "Nature Publishing Group",

    }

    RIS

    TY - JOUR

    T1 - Coffee consumption by type and risk of digestive cancer: a large prospective cohort study

    AU - Tran, Kim Tu

    AU - Coleman, Helen G.

    AU - McMenamin, Úna C.

    AU - Cardwell, Chris R.

    PY - 2019/5/1

    Y1 - 2019/5/1

    N2 - Background:Inverse associations have been observed between coffee consumption and liver cancer, but associations for other digestive cancers are unclear. Few previous studies have investigated coffee type (specifically instant or ground coffee) or a range of digestive cancer types within one cohort. We therefore investigated coffee consumption by type and digestive cancer risks in a population-based cohort.Methods:The UK Biobank captured self-reported coffee consumption and cancer-registry recorded incident digestive cancers. Hazard ratios (HRs) and 95% CIs were calculated using Cox regression. The risk of every type of digestive cancer was investigated in association with coffee consumption by dose–response and by coffee type (decaffeinated, instant and ground).Results:Over 7.5 years of follow-up, 3567 developed digestive cancer among 471,779 participants. There were 88 cases of hepatocellular carcinoma and a marked association was observed for hepatocellular carcinoma in coffee drinkers (HR 0.50, 95% CI 0.29, 0.87), which was similar for instant (HR 0.51, 95% CI 0.28, 0.93) and ground coffee (HR 0.47, 95% CI 0.20, 1.08). We did not observe significant consistently reduced risks of other individual digestive cancers amongst coffee drinkers.Conclusions:We found some evidence that coffee consumption was inversely associated with hepatocellular carcinoma which was similar by coffee type.

    AB - Background:Inverse associations have been observed between coffee consumption and liver cancer, but associations for other digestive cancers are unclear. Few previous studies have investigated coffee type (specifically instant or ground coffee) or a range of digestive cancer types within one cohort. We therefore investigated coffee consumption by type and digestive cancer risks in a population-based cohort.Methods:The UK Biobank captured self-reported coffee consumption and cancer-registry recorded incident digestive cancers. Hazard ratios (HRs) and 95% CIs were calculated using Cox regression. The risk of every type of digestive cancer was investigated in association with coffee consumption by dose–response and by coffee type (decaffeinated, instant and ground).Results:Over 7.5 years of follow-up, 3567 developed digestive cancer among 471,779 participants. There were 88 cases of hepatocellular carcinoma and a marked association was observed for hepatocellular carcinoma in coffee drinkers (HR 0.50, 95% CI 0.29, 0.87), which was similar for instant (HR 0.51, 95% CI 0.28, 0.93) and ground coffee (HR 0.47, 95% CI 0.20, 1.08). We did not observe significant consistently reduced risks of other individual digestive cancers amongst coffee drinkers.Conclusions:We found some evidence that coffee consumption was inversely associated with hepatocellular carcinoma which was similar by coffee type.

    UR - http://www.scopus.com/inward/record.url?scp=85065174644&partnerID=8YFLogxK

    U2 - 10.1038/s41416-019-0465-y

    DO - 10.1038/s41416-019-0465-y

    M3 - Article

    VL - 120

    SP - 1059

    EP - 1066

    JO - British Journal of Cancer

    T2 - British Journal of Cancer

    JF - British Journal of Cancer

    SN - 0007-0920

    ER -

    Download

    Download as: RIS